» Articles » PMID: 25505712

Prevention Strategies for Gastric Cancer: a Global Perspective

Overview
Journal Clin Endosc
Date 2014 Dec 16
PMID 25505712
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the substantial burden of gastric cancer worldwide, population strategies for primary prevention have not been introduced in any country. Recognizing the causal role of Helicobacter pylori infection, there is increasing interest in population-based programs to eradicate the infection to prevent gastric cancer. Nonetheless, the paucity of available evidence on feasibility and effectiveness has prevented implementation of this approach. There are very few secondary prevention programs based on screening with endoscopy or radiography, notably in the Republic of Korea and Japan, two of the countries with the highest incidence rates of gastric cancer. In Korea, where the organized screening program is in place, survival rate of gastric cancer is as high as 67%. More research is needed to quantify the specific contribution of the screening program to observed declines in mortality rates. Gastric cancer screening is unlikely to be feasible in many Low-Middle Income Countries where the gastric cancer burden is high. Prevention strategies are still under development and the optimal approach may differ depending on local conditions and societal values. The present review gives an overview of the etiology and burden of the disease, and possible prevention strategies for countries and regions confronted with a significant burden of disease.

Citing Articles

Global burden of five major types of gastrointestinal cancer.

Singh A Prz Gastroenterol. 2025; 19(3):236-254.

PMID: 39802976 PMC: 11718493. DOI: 10.5114/pg.2024.141834.


Investigating the causal association between serum uric acid levels and gastric cancer risk: a Mendelian randomization study.

Zhao X, Ding N Sci Rep. 2024; 14(1):26165.

PMID: 39478158 PMC: 11525654. DOI: 10.1038/s41598-024-77788-7.


Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer.

Mazurek M, Szewc M, Sitarz M, Dudzinska E, Sitarz R Cancers (Basel). 2024; 16(18).

PMID: 39335135 PMC: 11430327. DOI: 10.3390/cancers16183163.


Circulating long noncoding RNA, Zfpm2-As1, and XIST based on medical data analysis are potential plasma biomarkers for gastric cancer diagnosis.

Liang H, Li H, Xia N, Chen J, Gao L, Liu H Technol Health Care. 2024; 32(6):4919-4928.

PMID: 38820035 PMC: 11612959. DOI: 10.3233/THC-232033.


Gastric Cancer: A Comprehensive Literature Review.

Mithany R, Shahid M, Manasseh M, Saeed M, Aslam S, Mohamed M Cureus. 2024; 16(3):e55902.

PMID: 38595903 PMC: 11003650. DOI: 10.7759/cureus.55902.


References
1.
Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H . Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol. 2003; 15(8):885-91. DOI: 10.1097/00042737-200308000-00009. View

2.
Capelle L, de Vries A, Haringsma J, Borg F, de Vries R, Bruno M . The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010; 71(7):1150-8. DOI: 10.1016/j.gie.2009.12.029. View

3.
Riecken B, Pfeiffer R, Ma J, Jin M, Li J, Liu W . No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. Prev Med. 2001; 34(1):22-8. DOI: 10.1006/pmed.2001.0925. View

4.
Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J . Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study. Int J Cancer. 2014; 136(2):425-34. PMC: 4354768. DOI: 10.1002/ijc.29005. View

5.
Dixon M . Gastrointestinal epithelial neoplasia: Vienna revisited. Gut. 2002; 51(1):130-1. PMC: 1773259. DOI: 10.1136/gut.51.1.130. View